A private equity firm founded in 2014 and is based in New York and Montreal. The firm manages the a fund that provides equity and equity-like investments in high growth companies in healthcare technology verticals, with a focus on surgery. The size of investments generally fall under the range of $2-5 M per company, and the firm seeks to make 2-3 investments per year. The firm looks globally with a strong focus in North America.
The firm is interested in highly innovative medical and surgical device companies, healthcare IT, healthcare services. The firm will not consider products in pharma or biotech industries. Medical device products should be patented and on the cusp of FDA clearance. The firm will support all classes of medical devices including 510k and PMA regulatory pathways. Healthcare IT companies are expected to demonstrate market traction prior to investment.
The firm seeks to work with companies with an experienced, motivated management team. The firm can act as the lead investor in all financing rounds, and requires a board seat in its portfolio companies.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply